This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Life Sciences Companies Undergoing Major Technology Shift

CONSHOHOCKEN, Pa., June 26, 2013 /PRNewswire/ -- The life sciences industry is undergoing a major IT platform shift that is transforming the way companies manage their businesses  – and that shift is accelerating, according to a survey report released by NextDocs today at the Drug Information Association ( DIA) 2013 Annual Meeting in Boston.  The report, The State of SharePoint in Life Sciences, is based on in-depth surveys with more than 100 leading life sciences and pharmaceutical companies, conducted with the aim of better understanding their use of technology to manage regulatory compliance. 

"The life sciences industry is experiencing a once-in-a-generation technology platform shift; a shift that is transforming how these companies manage clinical trials, regulatory submissions and manufacturing processes," said Zikria Syed, Chief Executive Officer of NextDocs. 

The report reveals that, over the past few years, life sciences companies have dramatically accelerated their shift away from legacy content management systems – and to Microsoft SharePoint for managing regulated content in validated systems.  Notably, nearly 37 percent of life sciences companies reported scaling back or replacing their legacy systems, such as EMC Documentum.  These companies are shifting towards open-standard platforms; nearly 65 percent say they have already shifted or plan to shift to a Microsoft SharePoint platform. 

The survey also reveals a dramatic expansion in use of Microsoft SharePoint to manage strategic aspects of their business, such as the management of regulated content in validated systems, as is required during clinical trials.  Four out of ten life sciences companies (43 percent) currently rely on Microsoft SharePoint, along with complimentary solutions, for regulated content management, and another 21 percent are actively planning such a transition. 

Companies are using Microsoft SharePoint as a platform, often combined with complimentary solutions, for quality management (e.g., CAPA, deviations and change control) (42 percent); managing clinical trial documents (eTMF) (37 percent); and managing documents for FDA submissions (32 percent).

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,416.85 +225.48 1.31%
S&P 500 2,021.25 +19.09 0.95%
NASDAQ 4,683.4070 +45.4130 0.98%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs